WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide ...

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight ...

Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a ...

Dr. Paras Agarwal said weight loss drugs like Mounjaro and Wegovy are for those at health risk from obesity, and lifestyle ...

Novo Nordisk India partners with Emcure Pharma to distribute and market Poviztra (semaglutide) nationwide, expanding access ...

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

Real-world data suggest that people who have already reduced their weight by other methods can still lose more by initiating tirzepatide.

Topline nimacimab Phase 2a study data showed clinically meaningful weight loss in nimacimab/semaglutide combination cohort versus semaglutide alone after 26 weeks of treatment; the data demonstrated a ...

Weight loss refers to a reduction in overall body weight, while fat loss specifically targets excess body fat, improving body ...